Henry M. Rinder

Henry M. Rinder

Auto-generated profile, based on publicly available information

Henry M. Rinder

Department of Laboratory Medicine Yale University School of Medicine New Haven Connecticut USA

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2020 in Hepatology
Verified
Journal Article
Closed access
Alberto ZanettoAlberto Zanetto
Alberto Zanetto
HRHenry M. Rinder
Henry M. Rinder
ECElena Campello
Elena Campello
GSGraziella Saggiorato
Graziella Saggiorato
YDYanghong Deng
Yanghong Deng
GGGuadalupe Garcia‐Tsao
Guadalupe Garcia‐Tsao

1 September 1997 in Journal of the American Academy of Dermatology
Verified
Journal Article
Open access
DGDouglas Grossman
Douglas Grossman
PHPeter W. Heald
Peter W. Heald
CWChao Wang
Chao Wang
HRHenry M. Rinder
Henry M. Rinder
Hypercoagulable states, which include the presence of anticardiolipin antibodies (ACAs), have been associated with skin ulceration. Resistance to activated protein C (APC), resulting from the factor V Leiden mutation, is a common risk factor for venous thrombosis. Its prevalence among patients with venous leg ulcers is not known. Our purpose was to determine the prevalence of factor V Leiden and ACA in patients with venous leg ulceration. Twenty-nine consecutive patients with venous leg ulcers were studied. Resistance to APC was first determined by functional assay based on the partial thromboplastin time. Patients with an abnormally low APC ratio were then subjected to molecular analysis for confirmation of factor V Leiden. Measurements of ACA were performed by enzyme-linked immunosorbent assay. APC resistance was detected in 11 of 26 patients. However, only 2 of these 11 patients (7.7% overall) were found to be heterozygous for the factor V Leiden mutation. ACA was present in neither patient with the Leiden mutation but was found in 6 of 21 patients tested (29% overall). The factor V Leiden mutation, unlike ACA, may not be more prevalent in patients with venous leg ulcers than in the general population. Our results emphasize the importance of molecular analysis for factor V Leiden in patients with APC resistance.

1 August 2003 in Drug and Alcohol Dependence
Verified
Journal Article
Closed access
TKThomas Richard Kosten
Thomas Richard Kosten
PGP.CHristopher Gottschalk
P.CHristopher Gottschalk
KTKaren Tucker
Karen Tucker
CRChristine S. Rinder
Christine S. Rinder
HDHolly M. Dey
Holly M. Dey
HRHenry M. Rinder
Henry M. Rinder

30 July 2023 in Journal of Clinical Apheresis
Verified
Journal Article
Closed access
JCJuan J. Silva Campos
Juan J. Silva Campos
EAElizabeth Abels
Elizabeth Abels
HRHenry M. Rinder
Henry M. Rinder
CTChristopher A. Tormey
Christopher A. Tormey
JJJeremy W. Jacobs
Jeremy W. Jacobs

1 January 2013
Verified
Book Chapter
Closed access
BSBrian Richard Smith
Brian Richard Smith
HRHenry M. Rinder
Henry M. Rinder

1 June 2009 in Clinics In Laboratory Medicine
Verified
Journal Article
Closed access
HRHenry M. Rinder
Henry M. Rinder